BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 969 filers reported holding BAXTER INTL INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,855,000 | -74.0% | 43,868 | -74.9% | 0.05% | -72.0% |
| Q3 2017 | $10,973,000 | +13.8% | 174,857 | +9.8% | 0.16% | +13.9% |
| Q2 2017 | $9,642,000 | -68.8% | 159,264 | -73.3% | 0.14% | -67.9% |
| Q1 2017 | $30,895,000 | +299.5% | 595,744 | +241.7% | 0.45% | +227.7% |
| Q4 2016 | $7,733,000 | -77.3% | 174,372 | -75.7% | 0.14% | -74.6% |
| Q3 2016 | $34,090,000 | +889.0% | 716,125 | +839.6% | 0.54% | +862.5% |
| Q2 2016 | $3,447,000 | -81.5% | 76,213 | -83.2% | 0.06% | -81.9% |
| Q1 2016 | $18,605,000 | +130.0% | 452,906 | +84.0% | 0.31% | +147.2% |
| Q3 2015 | $8,088,000 | +848.2% | 246,199 | +1918.7% | 0.12% | +1036.4% |
| Q2 2015 | $853,000 | -95.6% | 12,196 | -95.7% | 0.01% | -95.9% |
| Q1 2015 | $19,292,000 | -16.6% | 281,628 | -10.8% | 0.27% | -10.1% |
| Q4 2014 | $23,137,000 | -61.3% | 315,694 | -62.1% | 0.30% | -62.5% |
| Q3 2014 | $59,759,000 | +16.1% | 832,638 | +17.0% | 0.79% | +26.0% |
| Q2 2014 | $51,454,000 | -6.6% | 711,685 | -4.9% | 0.63% | -9.7% |
| Q1 2014 | $55,084,000 | +17.6% | 748,622 | +11.2% | 0.69% | +23.8% |
| Q4 2013 | $46,836,000 | -0.2% | 673,422 | -5.7% | 0.56% | +12.9% |
| Q3 2013 | $46,908,000 | +60.9% | 714,088 | +69.7% | 0.50% | +71.6% |
| Q2 2013 | $29,151,000 | – | 420,837 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |